Looking into the current session, Pfizer Inc. (PFE) shares are trading at $25.84, after a 0.39% increase. Moreover, over the ...

Construction work paused at 235 East 42nd Street, David Werner and Metro Loft’s massive office-to-resi conversion in Midtown ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The trend in the state is consistent with an uptick in several parts of the country, including New York and California.

Pfizer faces challenges from pricing pressures, a 2026 patent cliff, and weak R&D momentum. Click here to find out why I rate ...

The market offers significant opportunities driven by increasing demand for personalized therapies, especially in oncology and rare diseases. Targete ...

Pfizer is making significant strides in the oncology sector, boasting a robust lineup of cancer treatments. Its oncology ...

Pfizer ($PFE) may finally be turning the corner on its post-pandemic revenue challenges. The company recently reported ...

Pigot most recently served as chief commercial officer at Aerovate Therapeutics, which was developing a dry powder inhaled ...

The Score is a weekly review of the biggest stock moves and the news that drove them. Here is this week's installment: ...

Contract manufacturers have carved out a lucrative niche within the biopharma industry, and the value of their collective ...

Pfizer Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 8.3%. Earnings per share (EPS) also surpassed analyst estimates by 42%.